Corporate Alliance Partnership Program
Program Goals
- APAO will accept corporate partnership with organizations that share a common goal in improving the delivery and quality of care to people with cancer and related diseases.
- Facilitate interaction between external stakeholders, APAO leadership, and members of APAO.
- Partnership will enable APAO and its membership to engage in initiatives to decrease the burden and suffering for all people affected by cancer.
Why Choose Us
- APAO was the first organization dedicated to representing PAs specializing in oncology and maintains the largest membership of PAs compared to any organization representing advanced practice providers in oncology.
- The mission of APAO is to promote the utilization of PAs in the delivery of exceptional care to people with cancer and related disorders, which is achieved by providing a forum for information exchange and networking in oncology, advocating for health care policies that promote the utilization of PAs and facilitating the continuing education and professional development of PAs and other healthcare professionals in oncology.
Current Partners
Platinum Level | Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, visit www.syndax.com or follow the Company on X and LinkedIn.
Gold Level | Gilead and Kite Oncology
Gilead and Kite Oncology are working to transform how cancer is treated. We are innovating with next-generation therapies, combinations and technologies to deliver improved outcomes for people with cancer. We are purposefully building our oncology portfolio and pipeline to address the greatest gaps in care. From antibody-drug conjugate technologies and small molecules to cell therapy-based approaches, we are creating new possibilities for people with cancer.
Gold Level | Johnson & Johnson
Johnson & Johnson is a global healthcare leader, committed to solving the toughest health challenges and transforming lives through research, development, manufacture and distribution of medicines and medical technologies. The company’s Innovative Medicine business advances breakthrough science and develops transformational treatments in areas like oncology, immunology, neuroscience, and cardiopulmonary. In MedTech, the company is focused on developing and delivering cardiovascular, surgery, and vision solutions. Visit jnj.com to learn more.
FOR MORE INFORMATION ON THE CORPORATE ALLIANCE PARTNERSHIP PROGRAM, click here or email admin@apao.cc
Education Hub
Upcoming Events
